A detailed history of Black Rock Inc. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,110,309 shares of PMVP stock, worth $5.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,110,309
Previous 3,229,797 3.7%
Holding current value
$5.13 Million
Previous $10 Million 47.19%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$1.51 - $3.12 $180,426 - $372,802
-119,488 Reduced 3.7%
3,110,309 $5.29 Million
Q4 2023

Feb 13, 2024

SELL
$1.23 - $6.6 $1.68 Million - $9.02 Million
-1,366,581 Reduced 29.73%
3,229,797 $10 Million
Q3 2023

Nov 13, 2023

SELL
$6.01 - $8.93 $484,706 - $720,204
-80,650 Reduced 1.72%
4,596,378 $28.2 Million
Q2 2023

Aug 11, 2023

BUY
$3.94 - $6.27 $2.55 Million - $4.06 Million
646,859 Added 16.05%
4,677,028 $29.3 Million
Q1 2023

May 12, 2023

BUY
$4.77 - $9.16 $2.76 Million - $5.3 Million
578,802 Added 16.77%
4,030,169 $19.2 Million
Q4 2022

Feb 13, 2023

BUY
$8.17 - $12.95 $743,829 - $1.18 Million
91,044 Added 2.71%
3,451,367 $30 Million
Q3 2022

Nov 14, 2022

BUY
$11.4 - $17.18 $24,840 - $37,435
2,179 Added 0.06%
3,360,323 $40 Million
Q2 2022

Aug 12, 2022

BUY
$9.23 - $22.43 $6.63 Million - $16.1 Million
717,794 Added 27.19%
3,358,144 $47.9 Million
Q1 2022

May 12, 2022

BUY
$14.86 - $23.55 $1.49 Million - $2.37 Million
100,526 Added 3.96%
2,640,350 $55 Million
Q4 2021

Feb 10, 2022

BUY
$19.99 - $30.24 $7.03 Million - $10.6 Million
351,901 Added 16.08%
2,539,824 $58.7 Million
Q3 2021

Nov 09, 2021

BUY
$26.84 - $36.58 $7.24 Million - $9.87 Million
269,789 Added 14.07%
2,187,923 $65.2 Million
Q2 2021

Aug 11, 2021

BUY
$28.01 - $36.01 $53.7 Million - $69.1 Million
1,918,134 New
1,918,134 $65.5 Million

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $75.3M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.